Tandem Diabetes Care Inc
(BSP:T2ND34)
R$
5.8
-0.38 (-6.15%)
Market Cap: 397.47 Mil
Enterprise Value: 1.23 Bil
PE Ratio: 0
PB Ratio: 8.86
GF Score: 45/100 Tandem Diabetes Care Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 07:30PM GMT
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley.
It's my pleasure to have Tandem Diabetes with us today; John Sheridan, President and CEO; and Leigh Vosseller, EVP and CFO.
Before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. (Operator Instructions)
And with that, John, Leigh, thank you both for joining us today.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
Thank you for having us. It's nice to be here.
Leigh A. Vosseller
Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer
Thank you.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot